Showing 1 - 15 results of 15 for search 'Sybren L Meijer', query time: 0.05s
Refine Results
-
1
-
2
Microscopic tumor spread beyond (echo)endoscopically determined tumor borders in esophageal cancer by Melanie Machiels, Maurits L. van Montfoort, Nikki B. Thuijs, Mark I. van Berge Henegouwen, Tanja Alderliesten, Sybren L. Meijer, Jeanin E. van Hooft, Maarten C. C. M. Hulshof
Published 2019-12-01
Article -
3
-
4
Feasibility of Optical Coherence Tomography (OCT) for Intra-Operative Detection of Blood Flow during Gastric Tube Reconstruction by Sanne M. Jansen, Mitra Almasian, Leah S. Wilk, Daniel M. de Bruin, Mark I. van Berge Henegouwen, Simon D. Strackee, Paul R. Bloemen, Sybren L. Meijer, Suzanne S. Gisbertz, Ton G. van Leeuwen
Published 2018-04-01
Article -
5
Inhibition of miR-142-5P ameliorates disease in mouse models of experimental colitis. by Nicolette W Duijvis, Perry D Moerland, Cindy Kunne, Monique M W Slaman, Faas H van Dooren, Esther W Vogels, Wouter J de Jonge, Sybren L Meijer, Kees Fluiter, Anje A Te Velde
Published 2017-01-01
Article -
6
miR-511 Deficiency Protects Mice from Experimental Colitis by Reducing TLR3 and TLR4 Responses via WD Repeat and FYVE-Domain-Containing Protein 1 by Shafaque Rahman, Jolien Vandewalle, Patricia H. P. van Hamersveld, Caroline Verseijden, Olaf Welting, Aldo Jongejan, Pierina Casanova, Sybren L. Meijer, Claude Libert, Theodorus B. M. Hakvoort, Wouter J. de Jonge, Sigrid E. M. Heinsbroek
Published 2021-12-01
Article -
7
Dietary Curdlan Enhances Bifidobacteria and Reduces Intestinal Inflammation in Mice by Shafaque Rahman, Mark Davids, Patricia H. P. van Hamersveld, Olaf Welting, Hakim Rahaoui, Frank Schuren, Sybren L. Meijer, René M. van den Wijngaard, Theodorus B. M. Hakvoort, Wouter J. de Jonge, Sigrid E. M. Heinsbroek
Published 2021-04-01
Article -
8
Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease. by Jessica R de Bruyn, Marte A Becker, Jessica Steenkamer, Manon E Wildenberg, Sybren L Meijer, Christianne J Buskens, Willem A Bemelman, Mark Löwenberg, Cyriel Y Ponsioen, Gijs R van den Brink, Geert R D'Haens
Published 2018-01-01
Article -
9
Loss of intestinal sympathetic innervation elicits an innate immune driven colitis by Rose A. Willemze, Olaf Welting, Patricia van Hamersveld, Caroline Verseijden, Laurens E. Nijhuis, Francisca W. Hilbers, Sybren L. Meijer, Balthasar A. Heesters, Joost H. A. Folgering, Harold Darwinkel, Philippe Blancou, Margriet J. Vervoordeldonk, Jurgen Seppen, Sigrid E. M. Heinsbroek, Wouter J. de Jonge
Published 2019-01-01
Article -
10
Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases. by Berbel L M Ykema, Sanne J M Hoefnagel, Lisanne S Rigter, Liudmila L Kodach, Gerrit A Meijer, Flora E van Leeuwen, Hina N Khan, Petur Snaebjornsson, Berthe M P Aleman, Annegien Broeks, Sybren L Meijer, Kenneth K Wang, Beatriz Carvalho, Kausilia K Krishnadath, Monique E van Leerdam, GIOCA-OES
Published 2020-01-01
Article -
11
Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric... by Sandor Schokker, Stephanie O. van der Woude, Jessy Joy van Kleef, Daan J. van Zoen, Martijn G. H. van Oijen, Banafsche Mearadji, Ludo F. M. Beenen, Charlotte I. Stroes, Cynthia Waasdorp, R. Aarti Jibodh, Aafke Creemers, Sybren L. Meijer, Gerrit K. J. Hooijer, Cornelis J. A. Punt, Maarten F. Bijlsma, Hanneke W. M. van Laarhoven
Published 2019-06-01
Article -
12
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT) by Charlotte I Stroes, Sandor Schokker, Mohammed Khurshed, Stephanie O van der Woude, Ron AA Mathôt, Marije Slingerland, Judith de Vos-Geelen, Massimo Zucchetti, Cristina Matteo, Erik van Dijk, Bauke Ylstra, Victor Thijssen, Sarah Derks, Tesfay Godefa, Willemieke Dijksterhuis, Gerben E Breimer, Otto M van Delden, Rob HA Verhoeven, Sybren L Meijer, Maarten F Bijlsma, Hanneke WM van Laarhoven
Published 2022-06-01
Article -
13
Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies by Sanne J. M. Hoefnagel, Willem J. Koemans, Hina N. Khan, Jan Koster, Sybren L. Meijer, Jolanda M. van Dieren, Liudmila L. Kodach, Johanna W. van Sandick, Silvia Calpe, Carmen M. del Sancho-Serra, Ana C. P. Correia, Mark I. Van Berge Henegouwen, Suzanne S. Gisbertz, Maarten C. C. M. Hulshof, Sandro Mattioli, Manon C. W. Spaander, Kausilia K. Krishnadath
Published 2022-09-01
Article -
14
Dynamic clonal equilibrium and predetermined cancer risk in Barrett’s oesophagus by Pierre Martinez, Margriet R. Timmer, Chiu T. Lau, Silvia Calpe, Maria del Carmen Sancho-Serra, Danielle Straub, Ann-Marie Baker, Sybren L. Meijer, Fiebo J. W. ten Kate, Rosalie C. Mallant-Hent, Anton H. J. Naber, Arnoud H. A. M. van Oijen, Lubbertus C. Baak, Pieter Scholten, Clarisse J. M. Böhmer, Paul Fockens, Jacques J. G. H. M. Bergman, Carlo C. Maley, Trevor A. Graham, Kausilia K Krishnadath
Published 2016-08-01
Article -
15
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Respo... by Charlotte I. Stroes, Sandor Schokker, Remco J. Molenaar, Ron A. A. Mathôt, Maarten F. Bijlsma, Stephanie O. van der Woude, João P. Belo Pereira, Gerrit K. J. Hooijer, Rob H. A. Verhoeven, Annemieke Cats, Cecile Grootscholten, Johanna W. van Sandick, Geert-Jan Creemers, Grard A. P. Nieuwenhuijzen, Nadia Haj Mohammad, Jelle P. Ruurda, Sybren L. Meijer, Maarten C. C. M. Hulshof, Mark I. van Berge Henegouwen, Hanneke W. M. van Laarhoven
Published 2021-02-01
Article